Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy

References

• Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991; 14: 260–9
   PubMed Web of Science ®Google Scholar
• Lewis E, Hunsicker L, Bain R, Rhode R. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–62
   PubMed Web of Science ®Google Scholar
• Nielsen F S, Rossing P, Gall M-A, Skøtt P, Smidt U M, Parving H-H. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 1994; 43: 1108–13
   PubMed Web of Science ®Google Scholar
• White W B, Pickering T G, Morganroth J, et al. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 1991; 4: 890–6
   PubMed Web of Science ®Google Scholar
• Jamieson M J, Fowler G, MacDonald T M, et al. Bench and ambulatory field evaluation of the A&D TM-2420 automated sphygmomanometer. J Hypertens 1990; 8: 599–605
   PubMed Web of Science ®Google Scholar
• Clark S, Fowlie S, Coats A, et al. Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM-2420 according to the AAMI recommendations. J Hum Hypertens 1991; 5: 77–82
   PubMed Web of Science ®Google Scholar
• Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271–4
   PubMed Web of Science ®Google Scholar
• Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643–51
   PubMed Web of Science ®Google Scholar
• Parving H-H. Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man—on the pathogenesis of hypertensive and diabetic microangiopathy. Dan Med Bull 1975; 22: 217–33
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539–44
   PubMed Web of Science ®Google Scholar
• Ingerslev J. A sensitive ELISA for von Willebrand factor (vWF: Ag). Scand J Clin Lab Invest 1987; 47: 143–9
   PubMed Web of Science ®Google Scholar
• Spencer K, Price C P. Kinetic immunoturbidimetry: the estimation of albumin. Clin Chim Acta 1979; 95: 263–76
   PubMed Web of Science ®Google Scholar
• Gall M-A, Borch-Johnsen K, Nielsen F S, Hougaard P, Parving H-H. Micro- and macroalbuminuria as predictors of mortality in non-insulin-dependent diabetes [abstract]. Diabetologia 1993; 36(Suppl 1)A207
   PubMedGoogle Scholar
• Nelson R G, Pettitt D J, Carraher M J, Baird H R, Knowler W C. Effect of proteinuria on mortality in NIDDM. Diabetes 1988; 37: 1499–504
   PubMed Web of Science ®Google Scholar
• Gall M-A, Rossing P, Skøtt P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655–61
   PubMed Web of Science ®Google Scholar
• Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 1987; 3: 463–524
   PubMedGoogle Scholar
• Nielsen F S, Voldsgaard A I, Gall M-A, et al. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1993; 36: 438–44
   PubMed Web of Science ®Google Scholar
• Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219–26
   PubMed Web of Science ®Google Scholar
• Chen J-W, Gall M-A, Deckert M, Jensen J S, Parving H-H. Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. Br Med J 1995; 311: 1405–6
   PubMed Web of Science ®Google Scholar
• Parving H-H, Nielsen F S, Bang L E, et al. Macro-microangiopathy and endothelial dysfunction in NIDDM patients and without diabetic nephropathy. Diabetologia 1996; 39: 1590–7
   PubMed Web of Science ®Google Scholar
• Stehouwer C DA, Nauta J JP, Zeldenrust G C, Hackeng W HL, Donker A JM, den Ottolander G JH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340(ii)319–23
   PubMedGoogle Scholar
• Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navelesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 1995; 18: 1–9
   PubMed Web of Science ®Google Scholar
• Parving H-H, Smidt U M. Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy. Diabetic Med 1986; 3: 312–15
   PubMed Web of Science ®Google Scholar
• Parving H-H, Kastrup J, Smidt U M. Reduced transcapillary escape rate of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1985; 28: 797–801
   PubMed Web of Science ®Google Scholar
• Sandeman D D, Shore A C, Tooke J E. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992; 327: 760–4
   PubMed Web of Science ®Google Scholar
• Parving H-H, Viberti G C, Keen H, Christiansen J S, Lassen N A. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983; 32: 943–9
   PubMed Web of Science ®Google Scholar
• Shore A C, Jaap A J, Tooke J E. Capillary pressure in patients with NIDDM. Diabetes 1994; 43: 1198–202
   PubMed Web of Science ®Google Scholar
• Williams S A, Boolell M, MacGregor G A, Smaje L H, Wasserman S M, Tooke J E. Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci 1990; 79: 5–8
   Web of Science ®Google Scholar
• Sandeman D D, Shore A C, Tooke J E. Captopril reduces nailfold capillary pressure in type 1 diabetic patients with established nephropathy [abstract]. Diabetic Med 1991; 8: 37A–38A
   Google Scholar
• Shore A C, Donohoe A, Jaap A J, Tooke J E. Capillary pressure is reduced by ramipril in type 1 diabetic patients with microalbuminuria [abstract]. Diabetologia 1993; 36: A221
   Web of Science ®Google Scholar
• Morelli E, Loon N, Meyer T W, Peters W, Myers B D. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76–82
   PubMed Web of Science ®Google Scholar
• Boneu B, Abbal M, Plante J, Bierne R. Factor-VIII complex and endothelial damage. Lancet 1975; 75(i)1430
   Google Scholar
• Stehouwer C DA, Donker A JM. Urinary albumin excretion and cardiovascular disease risk in diabetes mellitus: is endothelial dysfunction the missing link?. J Nephrol 1993; 6(2)72–92
   Google Scholar